Double maintains 2 strategies that include ARWR - Arrowhead Pharmaceuticals, Inc.
SeekingAlpha
RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with stability and specificity. Explore more details here.
Yahoo
Key Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have significant...
SeekingAlpha
Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for my updated look at ARWR stock.
Yahoo
On Monday, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic designed to reduce liver production of complement component 3 (C3) as a potential therapy for various complement-mediated diseases. ARO-C3 is designed to reduce hepatocyte production of complement C3 as a potential treatment for various complement-mediated renal diseases. The dysregulated activity of the co
Yahoo
PASADENA, Calif., March 10, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic designed to reduce liver production of complement component 3 (C3) as a potential therapy for various complement mediated diseases. The company plans to present additional results at a medical meeting in 2025.
Yahoo
PASADENA, Calif., March 06, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of two first-in-class clinical stage, RNAi-based investigational therapeutics being developed for the treatment of obesity and metabolic diseases. The two candidates, ARO-INHBE and ARO-ALK7, have the potential to reduce body weight and fat mass with a novel mechanism of action that may lead to improved preservation of lean muscle mass compar
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 54.18% | $2.00B | -29.07% | 0.00% |
NTLA | 52.50% | $755.67M | -70.78% | 0.00% |
FATE | 49.17% | $88.24M | -89.02% | 0.00% |
BEAM | 48.63% | $1.85B | -37.74% | 0.00% |
RGNX | 46.97% | $353.11M | -65.19% | 0.00% |
IMNM | 46.92% | $583.44M | -68.94% | 0.00% |
CRNX | 46.70% | $2.92B | -34.08% | 0.00% |
RCKT | 44.99% | $671.77M | -75.23% | 0.00% |
COGT | 44.66% | $651.22M | -16.98% | 0.00% |
CRSP | 44.63% | $2.93B | -47.07% | 0.00% |
IONS | 44.56% | $4.56B | -34.42% | 0.00% |
RXRX | 43.70% | $2.13B | -40.76% | 0.00% |
YMAB | 43.29% | $217.05M | -66.71% | 0.00% |
ACET | 42.32% | $59.86M | -67.96% | 0.00% |
VSH | 42.14% | $2.16B | -28.21% | 2.94% |
BN | 39.49% | $81.49B | +33.48% | 0.65% |
RYTM | 39.45% | $3.29B | +27.07% | 0.00% |
ROIV | 39.41% | $7.19B | -12.42% | 0.00% |
URBN | 39.18% | $5.11B | +32.24% | 0.00% |
PGEN | 39.14% | $435.18M | +5.71% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 63.07% | $47.13M | 0.5% |
XBI | 61.53% | $4.76B | 0.35% |
IBB | 57.81% | $5.61B | 0.45% |
CPRJ | 57.27% | $48.38M | 0.69% |
ARKG | 51.09% | $936.86M | 0.75% |
PINK | 50.33% | $138.92M | 0.5% |
BBH | 49.69% | $358.88M | 0.35% |
IWC | 49.39% | $797.08M | 0.6% |
PBE | 49.23% | $224.98M | 0.58% |
FBT | 48.67% | $1.08B | 0.56% |
IWO | 47.16% | $10.72B | 0.24% |
IWM | 46.78% | $62.65B | 0.19% |
VTWO | 46.75% | $10.92B | 0.07% |
XPH | 46.44% | $158.14M | 0.35% |
KJUL | 46.37% | $155.05M | 0.79% |
PTH | 46.25% | $107.91M | 0.6% |
BTC | 46.11% | $3.28B | 0.15% |
SCHA | 45.98% | $15.94B | 0.04% |
KAPR | 45.49% | $144.85M | 0.79% |
RSPA | 45.43% | $292.67M | 0% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -34.55% | $416.76M | 1.43% |
VIXY | -30.73% | $195.31M | 0.85% |
TAIL | -24.78% | $87.65M | 0.59% |
USDU | -18.41% | $206.96M | 0.5% |
UUP | -16.01% | $325.79M | 0.77% |
TPMN | -15.57% | $33.32M | 0.65% |
CTA | -13.46% | $978.30M | 0.76% |
TBIL | -11.44% | $5.39B | 0.15% |
UNG | -10.40% | $397.59M | 1.06% |
DBE | -9.15% | $55.52M | 0.77% |
KMLM | -8.88% | $218.49M | 0.9% |
WEAT | -6.89% | $115.75M | 0.28% |
USO | -5.81% | $972.70M | 0.6% |
UGA | -5.53% | $87.23M | 0.97% |
BNO | -5.27% | $99.25M | 1% |
USL | -5.10% | $47.77M | 0.85% |
DBA | -5.02% | $829.48M | 0.93% |
PDBC | -5.01% | $4.89B | 0.59% |
COMT | -4.90% | $684.20M | 0.48% |
GSG | -4.72% | $1.05B | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ULST | 0.01% | $585.14M | 0.2% |
BOXX | -0.02% | $5.77B | 0.1949% |
SPSK | -0.08% | $300.65M | 0.5% |
VRIG | -0.24% | $1.44B | 0.3% |
JMST | 0.27% | $3.54B | 0.18% |
BCD | 0.46% | $250.79M | 0.3% |
GBIL | 0.55% | $6.30B | 0.12% |
SGOV | 1.11% | $39.98B | 0.09% |
BIL | -1.37% | $41.88B | 0.1356% |
COM | 1.53% | $242.21M | 0.72% |
SHYD | 1.53% | $319.95M | 0.35% |
CMDY | -1.84% | $313.96M | 0.28% |
IBTP | 1.95% | $111.57M | 0.07% |
BILZ | -1.99% | $734.41M | 0.14% |
GCC | 2.00% | $149.77M | 0.55% |
FTGC | -2.07% | $2.52B | 1.02% |
USFR | 2.24% | $18.53B | 0.15% |
CORN | 2.27% | $52.17M | 0.2% |
XHLF | -2.29% | $1.06B | 0.03% |
BCI | -2.40% | $1.45B | 0.26% |
Current Value
$12.131 Year Return
Current Value
$12.131 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -13.16% | $23.50B | +25.53% | 1.05% |
LITB | -11.87% | $41.93M | -46.48% | 0.00% |
CYCN | -10.49% | $7.07M | -17.41% | 0.00% |
PRPO | -8.96% | $8.36M | -11.96% | 0.00% |
NOC | -7.89% | $74.14B | +12.07% | 1.60% |
CCRN | -7.13% | $488.91M | -16.71% | 0.00% |
VHC | -6.18% | $35.77M | +37.68% | 0.00% |
SG | -5.78% | $3.00B | +5.36% | 0.00% |
VZ | -5.61% | $188.34B | +4.44% | 5.84% |
CHD | -5.56% | $26.66B | +5.00% | 1.03% |
KR | -5.02% | $48.68B | +16.46% | 1.77% |
TCTM | -4.92% | $3.92M | -82.22% | 0.00% |
K | -4.79% | $28.46B | +45.70% | 2.75% |
TTE | -4.41% | $135.10B | -10.80% | 5.37% |
NHTC | -4.09% | $59.75M | -26.80% | 15.56% |
PG | -3.56% | $397.45B | +8.55% | 2.32% |
HUSA | -3.40% | $11.76M | -47.55% | 0.00% |
EQC | -2.61% | $170.80M | +24.66% | 0.00% |
ED | -2.60% | $38.69B | +21.90% | 2.95% |
NEUE | -2.56% | $57.12M | +4.27% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INSP | -0.08% | $4.75B | -24.09% | 0.00% |
SRRK | 0.09% | $3.08B | +113.66% | 0.00% |
HEES | 0.32% | $3.51B | +50.35% | 1.17% |
T | -0.33% | $201.99B | +59.80% | 3.85% |
CAH | 0.34% | $33.50B | +25.01% | 1.47% |
KMB | -0.36% | $47.39B | +13.36% | 3.37% |
KDP | -0.37% | $47.68B | +13.32% | 2.55% |
SSL | 0.42% | $2.61B | -49.08% | 0.00% |
ZCMD | -0.45% | $32.02M | -17.53% | 0.00% |
CORT | -0.51% | $8.84B | +226.74% | 0.00% |
LTM | 0.53% | $9.43B | -100.00% | <0.01% |
HIHO | 0.53% | $7.92M | -15.09% | 6.67% |
DRD | -0.58% | $1.35B | +76.75% | 1.77% |
WRB | 0.59% | $26.45B | +22.49% | 0.51% |
PDCO | -0.59% | $2.77B | +17.86% | 2.49% |
GIS | -0.60% | $32.41B | -14.20% | 3.90% |
CMTL | -0.60% | $47.84M | -46.73% | 0.00% |
MO | 0.65% | $96.57B | +35.61% | 6.83% |
ROOT | 0.67% | $1.90B | +83.78% | 0.00% |
LOAR | -0.69% | $7.19B | +174.46% | 0.00% |